---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-051379"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:42:54.335352+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics Approves FY2025 Cash Bonuses: CEO Hedrick Gets $305,663, CFO Sims Gets $149,175

## Summary
- On Feb 9, 2026, Compensation Committee approved discretionary cash bonuses for Named Executive Officers for FY2025.
- CEO Marc H. Hedrick received a $305,663 cash bonus; total 2025 compensation was $5,566,732.
- CFO Andrew Sims received a $149,175 cash bonus; total 2025 compensation was $1,631,279.
- Former CMO Norman LaFrance, who stepped down in June 2024, received $0 compensation in FY2025.

## SEC filing metadata
- accession: 0001193125-26-051379
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/0001193125-26-051379-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/pstv-20260209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-051379
- JSON: https://secwatch.observer/filing/0001193125-26-051379.json
- Plain text: https://secwatch.observer/filing/0001193125-26-051379.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.